JP2024539930A5 - - Google Patents
Info
- Publication number
- JP2024539930A5 JP2024539930A5 JP2024524412A JP2024524412A JP2024539930A5 JP 2024539930 A5 JP2024539930 A5 JP 2024539930A5 JP 2024524412 A JP2024524412 A JP 2024524412A JP 2024524412 A JP2024524412 A JP 2024524412A JP 2024539930 A5 JP2024539930 A5 JP 2024539930A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- approximately
- less
- pharmaceutical composition
- asbti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271857P | 2021-10-26 | 2021-10-26 | |
| US63/271,857 | 2021-10-26 | ||
| PCT/US2022/047719 WO2023076260A1 (en) | 2021-10-26 | 2022-10-25 | Apical sodium-dependent transporter inhibitor compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539930A JP2024539930A (ja) | 2024-10-31 |
| JP2024539930A5 true JP2024539930A5 (enExample) | 2025-10-23 |
Family
ID=86158469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524412A Pending JP2024539930A (ja) | 2021-10-26 | 2022-10-25 | 頂端側ナトリウム依存性輸送体阻害剤組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230181527A1 (enExample) |
| EP (1) | EP4422632A4 (enExample) |
| JP (1) | JP2024539930A (enExample) |
| KR (1) | KR20240089019A (enExample) |
| CN (1) | CN118159270A (enExample) |
| AR (1) | AR127467A1 (enExample) |
| AU (1) | AU2022376147A1 (enExample) |
| CA (1) | CA3232317A1 (enExample) |
| CL (1) | CL2024001247A1 (enExample) |
| CO (1) | CO2024005059A2 (enExample) |
| IL (1) | IL311482A (enExample) |
| MA (1) | MA65143B2 (enExample) |
| MX (1) | MX2024004916A (enExample) |
| TW (1) | TW202333722A (enExample) |
| WO (1) | WO2023076260A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4424363B1 (en) | 2019-02-12 | 2026-04-29 | Mirum Pharmaceuticals, Inc. | Methods for increasing growth in pediatric subjects having cholestatic liver disease |
| WO2025235543A1 (en) * | 2024-05-07 | 2025-11-13 | Mirum Pharmaceuticals, Inc. | Methods for treating cholestatic pruritus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4137137A1 (en) * | 2010-05-26 | 2023-02-22 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| JP6217938B2 (ja) * | 2011-10-28 | 2017-10-25 | ルメナ ファーマシューティカルズ エルエルシー | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 |
| EP4424363B1 (en) * | 2019-02-12 | 2026-04-29 | Mirum Pharmaceuticals, Inc. | Methods for increasing growth in pediatric subjects having cholestatic liver disease |
-
2022
- 2022-10-24 TW TW111140276A patent/TW202333722A/zh unknown
- 2022-10-25 CA CA3232317A patent/CA3232317A1/en active Pending
- 2022-10-25 EP EP22888055.5A patent/EP4422632A4/en active Pending
- 2022-10-25 KR KR1020247013460A patent/KR20240089019A/ko active Pending
- 2022-10-25 JP JP2024524412A patent/JP2024539930A/ja active Pending
- 2022-10-25 WO PCT/US2022/047719 patent/WO2023076260A1/en not_active Ceased
- 2022-10-25 CN CN202280071656.5A patent/CN118159270A/zh active Pending
- 2022-10-25 MA MA65143A patent/MA65143B2/fr unknown
- 2022-10-25 AU AU2022376147A patent/AU2022376147A1/en active Pending
- 2022-10-25 US US17/973,194 patent/US20230181527A1/en active Pending
- 2022-10-25 MX MX2024004916A patent/MX2024004916A/es unknown
- 2022-10-25 IL IL311482A patent/IL311482A/en unknown
- 2022-10-26 AR ARP220102911A patent/AR127467A1/es unknown
-
2024
- 2024-04-22 CO CONC2024/0005059A patent/CO2024005059A2/es unknown
- 2024-04-22 CL CL2024001247A patent/CL2024001247A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12599602B2 (en) | Methods for treating cholestasis | |
| US20230138455A1 (en) | METHODS OF DOSING OF APICAL SODIUM-DEPENDENT BILE ACID TRANSPORTER INHIBITORS (ASBTIs) | |
| US20230181527A1 (en) | Apical sodium-dependent transporter inhibitor compositions | |
| RU2829466C2 (ru) | Способы лечения холестаза | |
| HK40112462A (en) | Apical sodium-dependent transporter inhibitor compositions | |
| HK40112370A (en) | Methods of dosing of apical sodium-dependent bile acid transporter inhibitors (asbtis) | |
| HK40065061B (en) | Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency | |
| HK40065061A (en) | Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiency | |
| HK40065058B (en) | Methods for increasing growth in pediatric subjects having cholestatic liver disease | |
| HK40065058A (en) | Methods for increasing growth in pediatric subjects having cholestatic liver disease |